Journal article
Stability of 3′-Deoxy-3′-[18F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time
Cancer biotherapy & radiopharmaceuticals, Vol.25(3), pp.361-363
06/2010
DOI: 10.1089/cbr.2009.0709
PMCID: PMC2936251
PMID: 20578842
Abstract
The purpose of this study was to evaluate the consistency of 3′-deoxy-3′[
18
F]fluorothymidine (FLT) standardized uptake values (SUVs) over the time course of imaging in head and neck cancer. Thirteen (13) subjects (all male; age: 56.9 ± 6.7 years) with squamous cell head and neck cancer, stage III/IV, were administered FLT and imaged dynamically for 1 hour over the tumor and then underwent whole-body (WB) imaging commencing at 74 ± 6 minutes. Imaging was repeated after 5 days of radiotherapy (10 Gy) and a single course of platinum-based chemotherapy. Volumes-of-interest (VOIs) were created on the last dynamic frame (SUV
60
). The pretherapy WB and midtherapy images were coregistered to the dynamic sequence and VOIs were applied. Mean and maximum SUVs (SUV
60
and SUV
WB
) and the change with treatment were evaluated. The correlations (Spearman's
ρ
) between SUV
60
and SUV
WB
for all VOIs (pre- and midtherapy,
n
= 108 data pairs) were 0.98 for mean and 0.97 for maximum SUVs (
p
< 0.0001). Average absolute differences between SUV
60
and SUV
WB
were 0.18 ± 0.15 and 0.29 ± 0.32 SUV units, respectively. Correlations (Spearman's
ρ
) between the change in SUV with therapy were 0.90 for mean and 0.89 for maximum SUV (
p
< 0.0001), with differences in the change values averaging 0.03 ± 0.36 and −0.17 ± 0.57 units, respectively. FLT SUVs are stable and comparable for images initiated between 55 and 100 minutes postinjection whether acquired pre- or midtherapy in head and neck cancer.
Details
- Title: Subtitle
- Stability of 3′-Deoxy-3′-[18F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time
- Creators
- Laura L Boles Ponto - Department of RadiologyYusuf Menda - Department of RadiologyKenneth Dornfeld - Department of BiochemistryTimothy J Tewson - Department of RadiologyG. Leonard Watkins - Department of RadiologyJohn Sunderland - Department of RadiologyMichael M Graham - Department of RadiologyJohn Buatti - Department of Radiation Oncology
- Resource Type
- Journal article
- Publication Details
- Cancer biotherapy & radiopharmaceuticals, Vol.25(3), pp.361-363
- DOI
- 10.1089/cbr.2009.0709
- PMID
- 20578842
- PMCID
- PMC2936251
- NLM abbreviation
- Cancer Biother Radiopharm
- ISSN
- 1084-9785
- eISSN
- 1557-8852
- Publisher
- Mary Ann Liebert, Inc
- Language
- English
- Date published
- 06/2010
- Academic Unit
- Radiology; Pharmaceutical Sciences and Experimental Therapeutics; Physics and Astronomy; Radiation Oncology; Neurosurgery; Otolaryngology
- Record Identifier
- 9984046909902771
Metrics
8 Record Views